Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1/2 2Phase 4 1Phase 2 1

Status

Completed 3Terminated 2Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Tumor-Agnostic 2Thoracic 2Head & Neck 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 154Breast Neoplasms 117Carcinoma, Non-Small-Cell Lung 66Triple Negative Breast Neoplasms 45Neoplasm Metastasis 45Neoplasms 44Lung Neoplasms 26Ovarian Neoplasms 25Squamous Cell Carcinoma of Head and Neck 24Stomach Neoplasms 23Melanoma 16Esophageal Neoplasms 16Adenocarcinoma 15Head and Neck Neoplasms 13Recurrence 12Esophageal Squamous Cell Carcinoma 12Cholangiocarcinoma 12Sarcoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 11Small Cell Lung Carcinoma 10Fallopian Tube Neoplasms 10Uterine Cervical Neoplasms 9Urinary Bladder Neoplasms 8Pancreatic Adenocarcinoma 8Colorectal Neoplasms 8Prostatic Neoplasms 7Inflammatory Breast Neoplasms 7Carcinoma, Pancreatic Ductal 7Breast Neoplasms, Male 7Biliary Tract Neoplasms 7

Interventions

Cisplatin 55Carboplatin 50pembrolizumab 42Paclitaxel 42Gemcitabine 28Pemetrexed 23Radiotherapy 21Magnetic Resonance Spectroscopy 20Radiotherapy, Intensity-Modulated 18Cetuximab 18Docetaxel 17Specimen Handling 16Nivolumab 16Fluorouracil 16Cyclophosphamide 14durvalumab 13Bevacizumab 13Sorafenib 12Radiation 11130-nm albumin-bound paclitaxel 11Sunitinib 10Platinum 101,2-diaminocyclohexaneplatinum II citrate 10osimertinib 9Oxaliplatin 8Irinotecan 8Ipilimumab 8Everolimus 8Drug Therapy 8Capecitabine 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Carcinoma × Albumin-Bound Paclitaxel × Clear all
NCT03976362 2026-02-25

KEYLYNK-008

Merck Sharp & Dohme LLC

Phase 3 Completed
851 enrolled 25 charts
Tumor-Agnostic

Carcinoma

NCT04879368 2025-07-17

INTEGRATEIIb

Australasian Gastro-Intestinal Trials Group

Phase 3 Active not recruiting
450 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT02392507 2020-11-19

A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

Eli Lilly and Company

Phase 2 Completed
54 enrolled 16 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT01431794 2020-01-22

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Terminated
23 enrolled 10 charts
Gastrointestinal

Carcinoma, Pancreatic Diseases

NCT02151149 2018-09-24

ABOUND 70+

Celgene

Phase 4 Completed
143 enrolled 25 charts
Thoracic

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

NCT00570674 2017-11-13

Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck

Dana-Farber Cancer Institute

Phase 1/2 Terminated
29 enrolled 13 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡